Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.

Raquel JimenezMiquel GranellMercè GironellaEugenia AbellaAntoni García-GuiñónAlbert OriolElena CabezudoVictoria ClapésJoan Alfons SolerLourdes EscodaJordi López-PardoCarlos Fernández de LarreaMaria Teresa CibeiraNatalia TovarIgnacio IsolaJoan BladéLaura Rosiñolnull null

Published in: European journal of haematology (2019)

In conclusion, pomalidomide and dexamethasone has limited efficacy in patients with advanced MM and soft-tissue plasmacytomas.

Keyphrases

multiple myeloma
soft tissue
high dose
low dose
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma